PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Czasopismo
2013 | 8 | 4 | 406-409
Tytuł artykułu

Hemothorax after chest tube insertion for pneumothorax as a complication of clopidogrel

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Hemorrhagic complications are recognized when anti-platelet agents are used during or after surgical procedures. We present a 69-year-old male patient who developed hemothorax after chest tube insertion for pneumothorax as a complication of clopidogrel and aspirin following ischemic heart disease. Hemothorax associated clopidogrel has rarely been reported and this is the first academic publication of this complication type following chest tube insertion shortly after the cessation of clopidogrel. Our case demonstrates the possibility of hemothorax when chest tube insertion is indicated under such conditions.
Słowa kluczowe
Wydawca
Czasopismo
Rocznik
Tom
8
Numer
4
Strony
406-409
Opis fizyczny
Daty
wydano
2013-08-01
online
2013-06-12
Twórcy
autor
  • Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, 310-0015, Mito, Ibaraki, Japan
  • Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, 310-0015, Mito, Ibaraki, Japan
  • Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, 310-0015, Mito, Ibaraki, Japan
  • Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, 310-0015, Mito, Ibaraki, Japan
  • Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, 310-0015, Mito, Ibaraki, Japan , hirosato@md.tsukuba.ac.jp
Bibliografia
  • [1] Mood GR, Bhatt DL. Clopidogrel and risk for acute coronary events. Curr Atheroscler Rep 2007; 9: 401–408 http://dx.doi.org/10.1007/s11883-007-0052-1[Crossref]
  • [2] Pollack CV Jr, Antman EM, Hollander JE; American College of Cardiology; American Heart Association. 2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med 2008; 52: 344–355 http://dx.doi.org/10.1016/j.annemergmed.2008.04.004[Crossref]
  • [3] Trawick EP, Yachimski PS. Management of nonvariceal upper gastrointestinal tract hemorrhage: controversies and areas of uncertainty. World J Gastroenterol 2012; 18: 1159–1165 http://dx.doi.org/10.3748/wjg.v18.11.1159[Crossref][WoS]
  • [4] Cook-Norris RH, Michaels JD, Weaver AL, et al. Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation. J Am Acad Dermatol 2011; 65: 584–591 http://dx.doi.org/10.1016/j.jaad.2011.02.013[WoS][Crossref]
  • [5] Chernoguz A, Telem DA, Chu E, Ozao-Choy J, Tammaro Y, Divino CM. Cessation of clopidogrel before major abdominal procedures. Arch Surg 2011; 146: 334–339 http://dx.doi.org/10.1001/archsurg.2011.23[Crossref][WoS]
  • [6] Menger R, Telford G, Kim P, et al. Complications following thoracic trauma managed with tube thoracostomy. Injury 2012; 43: 46–50 http://dx.doi.org/10.1016/j.injury.2011.06.420[Crossref][WoS]
  • [7] Yacovone ML, Kartan R, Bautista M. Intercostal artery laceration following thoracentesis. Respir Care 2010; 55: 1495–1498. [PubMed]
  • [8] Garg R, Uretsky BF, Lev EI. Anti-platelet and anti-thrombotic approaches in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2007; 70: 388–406 http://dx.doi.org/10.1002/ccd.21204[Crossref]
  • [9] Sharma S, Forrester JS. A novel regimen of alternate day clopidogrel would provide a cost-effective strategy to prevent very late stent thrombosis. Med Hypotheses 2012; 78: 166–170 http://dx.doi.org/10.1016/j.mehy.2011.10.018[Crossref][WoS]
  • [10] Boulé S, Marquié C, Vanesson-Bricout C, et al. Clopidogrel increases bleeding complications in patients undergoing heart rhythm device procedures. Pacing Clin Electrophysiol 2012; 35: 605–611 http://dx.doi.org/10.1111/j.1540-8159.2012.03354.x[Crossref][WoS]
  • [11] Haro Estarriol M, Alvarez Castillo LA, Baldó Padró X, Palou Rispau A, Rubio Garay M, Rubio Goday M. Bilateral hemothorax secondary to combined antiplatelet therapy with clopidogrel and acetylsalicylic acid. Arch Bronconeumol 2006; 42: 307–309 http://dx.doi.org/10.1157/13089544[Crossref]
  • [12] Shennib H, Endo M, Benhameid O. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting. Heart Surg Forum 2003: 6: 288–291 [PubMed]
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.-psjd-doi-10_2478_s11536-013-0166-5
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.